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ABSTRACT 
Background: In the last three decades role of pharmacist has changed dramatically. Patient counselling by pharmacist deals with providing 
information to the patients regarding the disease, Medications and lifestyle modifications. Diabetes mellitus (DM) is a severe medical and social 
problem that affects patient’s general wellbeing. Despite of the advances in understanding the disease and its management, the morbidity and 
mortality rate are in rise. 
Objective: To study the impact of pharmaceutical care services on quality of life in type 2 diabetes mellitus. To improve the knowledge, practice abd 
attitude, Quality of life of patients towards disease management.  
Methods: This is a prospective intervention study. It was carried out to determine the quality of life, based on which patients were counselled 
regarding disease, medication, nutrition, exercise, insulin, foot care, eye care, personal hygiene, self monitoring of glucose and self care. Out of 80 
patients, who are having diabetes mellitus and given patient counseling again collected after 1st and 2nd month. The paired t-test in Graph Pad 
InStat was used for statistical calculation.  
Results: The overall KAP scores for diabetes patients between test of baseline and final follow up was statistically significant (P< 0.001). The test 
group has shown increased medication adherence than control which shows the importance of patient counseling. 
Conclusion: The study concluded that pharmacist mediated patient counseling and the disease, medications and lifestyle modifications will 
improve the knowledge, attitude and practice, Quality of life and Glycemic control. 
Keywords: Patient counseling, KAP, Patient information leaflet and. Quality of life.  
 
INTRODUCTION 
Diabetes mellitus (DM) is a severe medical and social problem that 
affects patients general well being. Patient counselling by 
pharmacist deals with providing information to the patients 
regarding the disease, medications and lifestyle modifications. It has 
been shown to improve therapeutic outcomes [1].  
The World Health Organization (WHO) has established two main 
objectives in caring for diabetic patients: first, maintain the health 
and quality of life of individuals with diabetes through effective 
patient care and education and second, treat and prevent 
complications of the disease which should decrease morbidity and 
mortality as well as reduce the treatment lost [2]. 
Prevalence and incidence of diabetes among adults is high, varying 
between 2.8 percent to 4 percent in the year 2000. This number is 
expected to grow, resulting in over 350 million persons with 
diabetes world-wide in 2030 [3]. 
The number of people with diabetes mellitus (DM) is steadily 
increasing in Southeast Asia due to population growth, aging, 
urbanization, and the increasing prevalence of obesity as well as 
physical inactivity (WHO and IDF, 2004). 
Similarly, for India this increase is estimated to be 58%, from 51 
million people in 2010 to 87 million in 2030. The impacts of T2DM 
are considerable: as a lifelong disease, it increases morbidity and 
mortality and decreases the quality of life. Accordingly, morbidity 
and mortality in India there are 109 thousand deaths in 2004, 1,157 
million years of life lost in 2004, 2.263 million Disability Adjusted 
Life Years (DALY) in India during 2004 
The prevalence of DM is dramatically rising worldwide; 171 million 
people suffered from diabetes in 2000, and it is expected that this 
figure will double to 366 million by 2030 [5].  
[4]. 
The incidence increases with age, which, together with ageing of the 
population and possibly also with the high prevalence of overweight 
and obesity, will lead to a serious growth in the demand for 
diabetes-related health care [6]. 
During the last 20 years, the focus of community hospitals and 
pharmacies has shifted from a product centred approach to patient-
centred activities. This was the result of a growing awareness that 
not only the quality of the drug itself, but also that of 
pharmacotherapy are key in the effectiveness and safety.  
These issues, for example medication surveillance and patient 
education on compliance, a consequence of this shift, and due to the 
impact of diabetes on public health, the interest in interventions 
involving pharmacists in diabetes care has improved [5], [7].
Hyperglycaemia the hallmark of diabetes mellitus is associated with 
many different symptoms, which can be classified into short-term or 
long-term complications.  
  
Acute symptoms of untreated diabetes include thirst, weight loss, 
polyuria and blurred vision. Severe hyperglycemia can result in fatal 
diabetic keto-acidosis. Long-term complications include retinopathy, 
nephropathy and neuropathy.  
Furthermore, Type 2 diabetes mellitus is associated with a two to 
three fold increased risk of cardiovascular disease. Especially the 
long-term complications of diabetes are associated with high 
morbidity, high cost and decrease in quality of life. 
Poverty, non-compliance, lack of knowledge and poor follow ups are 
the factors observed in poor glycemic control [8]. Individuals with 
poor management of diabetes are at a greater risk of developing long 
term micro and macro vascular complications that lead to the 
damage of end organs such as kidney, heart, brain and eyes, affects 
the direct and indirect health care costs and overall quality of life [9].  
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The clinical pharmacy grew with the concept of pharmaceutical care 
or patient centred pharmacist care, the responsible provision of 
drug therapy for the purpose of achieving definite outcomes which 
improve the patients' quality of life. It involves the pharmacist's 
decision to avoid, initiate, maintain, or discontinue drug therapy, 
both of prescription and non- prescription drugs. It is thus practiced 
in collaboration with patients, physicians, nurses, and other health 
care workers. The ultimate goal of pharmaceutical care is to 
optimize the drug therapy and improve a patient's quality of life.  
Pharmacists are in a prime position to ensure that use of 
medications by the patients safely and appropriately. These 
outcomes can be achieved by influencing the cure of the disease, 
elimination or reduction of symptoms, arresting or slowing the 
disease progress, prevention and diagnosis of disease or desired 
alterations in the physiological process Patient counselling is an 
important means for achieving pharmaceutical care. It is defined as 
providing medication related information orally or in written form 
to the patients or their representatives, on topics like direction of 
use, advice on side effects, precautions, and storage, diet and life 
style modifications [3]. Patient counseling is interactive in nature 
and involves a one-to–one interaction between a pharmacist and a 
patient and/or caregiver [4].The ultimate goal of counseling is to 
provide information directed at encouraging safe and appropriate 
use of medications, thereby enhancing therapeutic outcomes [10]. 
Another important role of pharmacist is always being available to 
answer the questions of the patients. Overall, it is the pharmacist's 
role to help a diabetic patient in the best possible way to cope with 
their disease [11]. 
MATERIALS AND METHODS 
Study site: Department of General Medicine of a 300 bedded 
secondary care referral hospital located in Anantapur, A.P in South 
India. 
Study design: Prospective Interventional study. 
Study period: The prospective interventional study was conducted 
over a period of 6 months October 2013 – April 2014 
Study sample: 80 patients  
Study criteria: 
Inclusion Criteria 
 Patients of either sex aged above 40 years 
 Presence of signs and symptoms which are suspected to have 
diabetes 
 Patients who give consent to participate in this study  
Exclusion Criteria 
 Patients who are not willing to or unable to give consent to 
participate in study 
 Patients who are Pregnant and Paediatrics 
Sources of Data 
All necessary data was collected from the following sources 
1. Patient data collection form  
2. Patient case history 
3. Patient prescriptions 
3. Laboratory data 
4. Treatment profiles 
5. Microbiological data 
6. Patient counselling details - (Quality of life index, Patients KAP 
profile). 
Consent from hospital Authority 
The study was approved by the Hospital authority, by submitting a 
profoma of the study which includes the objectives, methodology, 
and the study was conducted with the expert guidance of seniors 
and junior physicians of the department selected.  
Literature Survey 
The literatures supporting the study were gathered from various 
sources such as British Medical Journal, American Medical Journal, 
Journal of Clinical Pharmacy and Therapeutics, Journal of Pharmacy 
Practice, The Annals of pharmacotherapy, Journal of national 
medical association, Indian journal on medical microbiology 
Statistical Tool  
The paired t-test in Graph Pad InStat was used for statistical 
calculation.  *P value < 0.001 was considered statistically significant. 
Study procedure: 
The formal permission from Hospital Medical director and Head of 
the Department of General medicine is going to obtain prior to 
initiation of the study. Personal meetings with the Head of the 
Department of General medicine, with a request to allow for Patient 
Counselling. After obtaining informed consent from the patient 
baseline parameters (age, gender, social status, economic status, and 
diagnosis and drug usage) were obtained by using a suitable data 
collection form.  A total of 80 subjects who are having diabetes are 
enrolled in our study. The sample was divided in to test (44) and 
control (36). All the baseline parameters are equally distributed in 
both test and control with a p value more than 0.05. The study was 
divided into baseline, 1st visit, and 2nd visit with a difference of two 
months for each visit. At base line after getting demography data, 
KAP scores and Quality of life score and blood glucose levels were 
obtained by KAP questionnaire for specialized formulations. After 
obtaining of baseline KAP, Quality of life scores and blood glucose 
levels, patient counselling was conducted in test group by oral and 
PIL. After counselling the scores were obtained in both test and 
control groups on 1st, 2nd
The present study involved 80 (100 %) as the sample, who 
participated and responded. Demographic details of the participants 
involved in the study was categorized based on gender and age 
distribution, the results of which were thoroughly analyzed and 
reported in Table 1. 




Table 1: Demographic Details 
S. No. Age 
(Years) 
Males Females No of Patients %  
Patients 
01 40-50 16 14 30 37.5 
02 51-60 13 12 25 31.25 
03 61-70 6 4 10 12.5 
04 71-80 4 3 7 8.75 
05 >80 3 5 8 10 
Total  45 (56.25 %)  35 (43.75 %) 80 100 
 Figure 1 shows that the distribution of diabetic cases according to the sex. Out of 80 cases 45 cases were male (56.25%) and 35 cases were female 




Fig. 1: Diabetic Cases Distribution Gender Basis 
Patients were categorized based on socio-economic status, results of 
which were thoroughly analyzed and reported in Table 2 
 
Table 2: Socio-economic status of patients 
S. No. Socio-economic Status No of Patients % Patients 
01 Low 42 52.5 
02 Middle 30 37.5 
03 High 08 10 
The details of medications distribution in study population is 
systematically analyzed and reported in Table 3. 
 
Table 3: Distribution of medications in patients 
S. 
No. 






01 Metformin 18 22.5 
02 Sulfonylureas + Metformin 38 47.5 
03 Insulin + Sulfonyl/Metformin 22 27.5 
04 Thiazolidinediones 02 2.5 
05 Not on any drugs - - 
 
Table 4: Duration of disease in patients 
S. No. Years No. of Patients % Patients 
01 < 1 21 26.25 
02 1 – 5 35 43.75 
03 5 – 10 17 21.25 
04 > 10 07 8.75 
 
Figure 2 Shows the educational status of the patients enrolled in the 
study. 
Major co-morbidities of the study population along with Type 2 
diabetes mellitus were clearly assessed and the results are reported 
in Table 5. 
 
 
Fig. 2: Educational status of the patients 
 
The disease duration of the patients, out of 80 cases 26.25% cases 
were having disease duration of < 1year, 43.75% cases were having 
disease duration of 1-5 years, 17 21.25% cases were having disease 
duration of 5-10 years and 8.75% patients were having disease 
duration of greater than 10 years, results are reported in Table 4. 
 
Table 5: Co-morbidities of the patients 
S. No. Major co-morbidity Males Females Total % of Patients 
01 T2DM 22 16 38 47.5 
02 T2DM + HTN 11 09 20 25 
03 
 
T2DM + HTN + 
Hypothyroidism 
01 02 03 3.75 
04 T2DM + Asthma 05 02 07 8.75 
05 T2DM + UTI 00 04 04 5 
06 T2DM + Nephropathy 01 - 01 1.25 
07 T2DM + Hypokalaemia 01 - 01 1.25 
 
Patients were also categorized based on their social history (alcohol 
& smoking habits), results are reported in Table 6 
Table 6: Patients social history 
S. No. Social history No of patients % of Patients 
01 Smoking 18 22.5 
02 Alcohol 04 5 
03 Smoking+ Alcohol 27 33.75 
04 Tobacco 06 7.5 
05 None 25 31.25 
Table 7 shows the KAP values of both test and control group of 
baseline and final follow up visit on diabetes mellitus patients. At the 
final follow up visit there is a significant improvement in the KAP 
scores with a *P-value of 0.001.  
*P value < 0.05 is significant and *
BL = Base Line, FF= Final Follow up 
P<0.001 is highly significant 
(Paired t test) 
Comparison of responses to QOL questionnaire was given on Table 8 
and the mean scores of the entire different group for various 
dimensions were mentioned. Physical endurances were 10.40±22.67 
before counseling and Social work was 22.18±31.75 in after 
counseling. The highest mean score in the domain Diet Tolerance 
63.12±1.47 before counseling and after counseling 79.53±14.84. 
 
 
Fig. 3: Comparison of responses between Control and Test on K 
A P on Baseline 
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Fig. 4: Comparison of responses between Control and Test on K 
A P on Follow up 
Figure 5 and Figure 6 reports the responses of counseling outcome 
in patients under control and test based on fasting blood glucose 
levels (FBG) and Post Prandial Blood Glucose levels (PPBS). 
 
 
Fig. 5: Response on counseling outcome in patients on FBG 
levels 
 
Fig. 6: Response on counseling outcome in patients on PPBS 
levels 
DISCUSSION 
In the current study, the demographic details of patients enrolled 
into the study shows that the majority are females and are 
housewives and are dependent on their family members or relatives 
for refilling the prescriptions and information. According to this 
study the diabetic prevalence was found to be high in patients of 
above 40 (37.5%) year’s age group in our study. In all age groups of 
Diabetic cases were more in males compared to females. Age group 
of 50 to 60 years with average disease duration of 1-5 years.  
Therapeutic management of patients enrolled in the study reveal 
that the patients were either on monotherapy (either Sulfonylureas 
or Metformin) or on dual therapy (combination of Sulfonylureas or 
Metformin). Patients who were only on diet and lifestyle 
modification for managing their diabetes showed greater 
improvement in blood glucose control and improved quality of life 
with education.  The prevalence of Diabetic cases was found to more 
in the age of 40 years. According to this study the diabetic 
prevalence was found to be high in patients of above 40 (37.5%) 
year’s age group. Out of 80 cases 45 cases were male (56.25%) and 
35 cases were female (43.75%). In all age groups of Diabetic cases 
was more in males compared to females. 
The socio economic status of the patients was found to be in 42 
cases were lower socio economic, 30 cases were middle socio 
economic and 08 cases were high socio economic. Results are based 
upon the patient annual income as low socio economic is >50,000, 
middle range is up to 1, 00,000 and high means that above 1, 00,000 
rupees. The educational status of the patients enrolled in the study. 
Out of 80 cases 33(41.25%) cases are with Illiterates (no formal 
education) followed by 27(33.75%) cases with primary education 
followed by 16(20%) patients with secondary education followed by 
4(5%) Cases with university level education. 
Social history shows that 18 (22.5%) cases were having smoking, 27 
(33.75%) cases were having smoking with alcohol consumption, 25 
(31.25%) cases were not having any social history and 06 (7.5%) 
patients were having tobacco chewing habits 
Disease distribution in study subjects found to be 38 (47.5%) cases 
were having Type-2 DM and 20 (25%) cases having Type-2 DM with 
Asthma and remaining percentages are type 2 diabetes with urinary 
tract infection, nephropathy, and hypokalemia respectively. 
The distribution of drugs in diabetic patients are as follows 18 
(22.5%) cases are on metformin and 38 (47.5%) cases are on 
combination of sulfonylurea’s and metformin and 22 (27.5%) cases 
are on insulin and sulfonylurea’s / metformin and 02 (2.5%) cases 
on thiazolidinediones. 
In this study, based on KAP questionnaire evaluation there was 
improvement in knowledge of the patients regarding basic concepts 
of the disease like accurate method for monitoring glucose control 
and the necessity of checking blood sugar at least once in a month, 
effect on different organs by untreated diabetes, importance of foot 
care in diabetes patients, management of hypoglycemic episodes etc 
after providing patient education. 
KAP values of both test and control group of baseline and final 
follow up visit on diabetes mellitus patients. At the final follow up 
visit there is a significant improvement in the KAP scores with a *
The F & P diabetic specific questionnaire was used to assess the QoL 
of the enrolled diabetic patients. All domains of the QoL instrument 
were affected in diabetes patients included in the study groups. 
Significant improvement (p<0.05) in the overall QOL was observed 
in the test group compared to the baseline. 
P-
value of 0.001.  
The overall QOL of both test and control groups were similar (*P 
value>0.05) at the baseline. However a non significant improvement 
in the overall QOL was observed in the first follow up and a 
significant improvement in the overall QOL was observed in the first 
and final follow up. In the 1st and 2nd follow up there was significant 
improvement in the QOL (*P value <0.05) when compared with the 
baseline. This was due to the fact that patient education influenced 
in proper glycemic control, which has reduced the diabetic 
symptoms that improved the patient’s enjoyment in day-to-day 
activities.The fasting blood glucose of the patients was non-
significant (*P value > 0.05) at the baseline. At the end of the visits 
the test group showed significant (*P>0.05) reduction in FBS from 
baseline to the final follow up. This significant change is due to the 
influence of patient education and counseling aids that helped the 
patients to understand more about the long term complications of 
poorly managed diabetes that in turn improved their compliance, 
diet maintenance and life style modifications. The fasting blood 
glucose levels of the patients. Initially at the baseline visit the control 
group average FBG levels of the patients was found to be 
196.2mg/dl, at the 1st visit average FBG was 189.8 mg/dl, at the 2rd 
visit the average FBG was found to be 185.6 mg/dl and. Similarly 
Post Prandial blood glucose (PPBS) level of the patients are 198.2 
mg/dl was base line and 1st and 2nd visits are 182.6&179.8 mg/dl. In 
test group also obtained the baseline, 1st and 2nd visit of FBS and 
PPBS levels are 185.4mg/dl,160.2mg/dl and 152.6mg/dl and 
2.2.5mg/dl,197.4mg/dl,172.2mg/dl respectively. From the above 
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graph gradual decrease in the FBG&PPBS of patients can be seen 
from the base line to second visit which shows the improved 
condition of the patients and it indicates the effect of counseling on 
the disease. 
 
Table 7: Knowledge, Attitude and Practice (K A P) Questionnaire Responses 
S. No. K A P Questions Control Test  
B L F F B L  F F 
01 Diabetes is a condition in which blood sugar levels is  
higher than the normal  
20 21 24 44 
02 1. Diabetes is caused due to increased intake of sugar or  
2. sugar products 
20 22 20 41 
03 Knowledge about the symptoms of diseases 25 25 24 44 
04 3. Most accurate methods of monitoring glucose control  
4. is checking blood sugar  
28 29 22 42 
05 5. Blood sugar and urine sugar tests tell about your  
6. control of diabetes 
30 34 30 41 
06 Do you accept that a diabetic patient should have  
regular blood glucose checking at least once in a  
month? 
31 33 32 43 
07 7. Do you know that suitable dietary changes; regular  
8. exercise and other lifestyle modifications are essential for 
9. blood glucose control? 
14 16 18 31 
08 Regular exercise improves blood circulation and 
there by helps in utilization of excess amount of glucose by tissues  
11 13 11 36 
09 Do you know that diabetic patients need not take care  
of their foot? 
14 15 16 32 
10 Footwear includes keeping your foot clean and  
wearing footwear of proper size with more comfort  
20 20 18 36 
11 Smoking and alcohol drinking can worsen your  
diabetic conditions  
30 31 32 43 
12 Do you know that diabetic patients may experience  
blurred vision, confusion and sweating, increase heart  
beat due to fall in blood glucose than normal? 
10 13 12 38 
13 In order to overcome the above situation, the patients  
should eat a teaspoonful sugar or a sugar candy  
13 14 14 26 
14 Health education is not important to control diabetes  12 12 16 44 
 * 0.015 P – Value 0.001 
The Comparisons of responses between Control and Test Groups in baseline and Final follow up of KAP Questionnaires are reported in Figure 3 and 
Figure 4 respectively.  
 
Table 8: Comparison of Responses to QoL questionnaires before and after counseling 
S. No. Dimension 
 
Average QOL mean *
 
P-value 
Before counseling After counseling 
 01 General Health 55.93±14.62 50.13±13.63 0.0128 
 02 Symptoms Bothered 50.73±16.51 32.26±14.56 0.001 
 03 Financial Worries 62.5±19.28 54.06±16.48 0.0001 
 04 Treatment Satisfaction 52.81±9.53 57.81±7.724 0.001 
 05  Emotional Mental Health 55.93±7.94 61.25±12.51 0.0003 
 06 Physical Endurances 10.40±22.67 50.35±21.56 0.0001 
 07 Diet Tolerance 63.12±1.47 79.53±14.84 0.001 
 08 Social Work 30.62±33.51 22.18±31.75 0.0035 
 09 Overall QoL 51.15±6.74 47.75±9.39 0.0002 
 
CONCLUSION 
Diabetes mellitus is a chronic disorder which will limits patient’s 
routine activities in terms of physical, social, psychological status. 
Pharmacist plays a major role in management of chronic disorders 
by providing Pharmaceutical care service. The present six month 
study also demonstrated the positive influence of patient counseling 
on knowledge, attitude and practices, various domains of quality of 
life and clinical and physiological parameters of diabetes mellitus. 
Our study concludes that pharmacist mediated individualised 
pharmaceutical care services have a positive impact on KAP, HRQOL, 
Glycemic control, and medication adherences which improves the 
therapeutic outcome of the patients.  
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